BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30526529)

  • 1. Maternally inherited diabetes and deafness complicated by mesangial galactose-deficient IgA1 deposits: a case report.
    Sugai K; Ueda H; Morimoto K; Tanaka M; Takahashi D; Nakashima A; Kato J; Takahashi H; Yamaguchi Y; Kawamura T; Hanaoka K; Miyazaki Y; Yokoo T
    BMC Nephrol; 2018 Dec; 19(1):350. PubMed ID: 30526529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Suzuki H; Yasutake J; Makita Y; Tanbo Y; Yamasaki K; Sofue T; Kano T; Suzuki Y
    Kidney Int; 2018 Mar; 93(3):700-705. PubMed ID: 29329643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
    Zhang K; Li Q; Zhang Y; Shang W; Wei L; Li H; Gao S; Yan T; Jia J; Liu Y; Lin S
    Kidney Blood Press Res; 2019; 44(5):1196-1206. PubMed ID: 31574506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
    Zhao L; Peng L; Yang D; Chen S; Lan Z; Zhu X; Yuan S; Chen G; Liu Y; Liu H
    Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune characteristics of renal allograft donors with mesangial IgA deposition.
    Wang Z; Zhang X; Han W; Yu G; Ying Z; Xu X; Wang M; Zhou X; Lv J; Zhang H
    Int Immunopharmacol; 2021 Feb; 91():107282. PubMed ID: 33370682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    Wada Y; Matsumoto K; Suzuki T; Saito T; Kanazawa N; Tachibana S; Iseri K; Sugiyama M; Iyoda M; Shibata T
    PLoS One; 2018; 13(11):e0206865. PubMed ID: 30388165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in mitochondrial DNA in a patient with diabetes, deafness and proteinuria.
    Adema AY; Janssen MC; van der Heijden JW
    Neth J Med; 2016 Dec; 74(10):455-457. PubMed ID: 27966441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy.
    Lee M; Suzuki H; Kato R; Fukao Y; Nakayama M; Kano T; Makita Y; Suzuki Y
    CEN Case Rep; 2021 Feb; 10(1):17-22. PubMed ID: 32676896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease caused by maternally inherited diabetes and deafness: a case report.
    Tanaka K; Ueno T; Yoshida M; Shimizu Y; Ogawa T; Nishisaka T; Kurashige T; Masaki T
    CEN Case Rep; 2021 May; 10(2):220-225. PubMed ID: 33125665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
    Yasutake J; Suzuki Y; Suzuki H; Hiura N; Yanagawa H; Makita Y; Kaneko E; Tomino Y
    Nephrol Dial Transplant; 2015 Aug; 30(8):1315-21. PubMed ID: 26109484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal imaging analysis of macular dystrophy in patient with maternally inherited diabetes and deafness (MIDD) with m.3243A>G mutation.
    Oishi N; Kubota D; Nakamoto K; Takeda Y; Hayashi M; Gocho K; Yamaki K; Igarashi T; Takahashi H; Kameya S
    Ophthalmic Genet; 2021 Jun; 42(3):304-311. PubMed ID: 33541179
    [No Abstract]   [Full Text] [Related]  

  • 12. The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy.
    Schmitt R; Ståhl AL; Olin AI; Kristoffersson AC; Rebetz J; Novak J; Lindahl G; Karpman D
    J Immunol; 2014 Jul; 193(1):317-26. PubMed ID: 24850720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
    Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients.
    Cheng W; Wang G; Guo W; Sun L; Xu X; Dong H; Ye S; Geng Y; Cheng H
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy.
    Fukao Y; Suzuki H; Kim JS; Jeong KH; Makita Y; Kano T; Nihei Y; Nakayama M; Lee M; Kato R; Chang JM; Lee SH; Suzuki Y
    J Clin Med; 2022 Jun; 11(11):. PubMed ID: 35683557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.
    Ebefors K; Liu P; Lassén E; Elvin J; Candemark E; Levan K; Haraldsson B; Nyström J
    BMC Nephrol; 2016 Apr; 17():40. PubMed ID: 27044423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galactose-Deficient IgA1 Deposits in Clear Cell Renal Cell Carcinoma-Related Henoch-Schönlein Purpura Nephritis.
    Zhao Y; Kim Y; Junghare M; Vakil V; Su X; Li F; Bu L
    Case Rep Nephrol; 2020; 2020():8828336. PubMed ID: 32908737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
    Suzuki H; Allegri L; Suzuki Y; Hall S; Moldoveanu Z; Wyatt RJ; Novak J; Julian BA
    Dis Markers; 2016; 2016():7806438. PubMed ID: 27647947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological and histopathological assessment of galactose-deficient immunoglobulin A1 deposition in kidney allografts: A multicenter prospective observational study.
    Sofue T; Oguchi H; Yazawa M; Tsujita M; Futamura K; Nishihira M; Toyoda M; Kano T; Suzuki H
    PLoS One; 2023; 18(2):e0281945. PubMed ID: 36795799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy.
    Cassol CA; Bott C; Nadasdy GM; Alberton V; Malvar A; Nagaraja HN; Nadasdy T; Rovin BH; Satoskar AA
    Nephrol Dial Transplant; 2020 Dec; 35(12):2123-2129. PubMed ID: 31369128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.